Company / Cash & Equivalents
ALUMIS INC. Cash & Equivalents History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$89.7M
FY2025
5-year range
$46.0M / $169.5M
FY2023-FY2025
Trend
-47.1%
vs FY2024
Sector context
#148 of 207
Health Care
What the data says
At $90M, ALUMIS INC.'s cash & equivalents ranks #148 of 207 in the Health Care sector. Improved from $46M to $90M over the past 2 years.
Based on SEC 10-K filings.
$90M in FY2025.
Improved from $46M to $90M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#148 of 207 in Health CareTop 71% of 207This company $89.7M Sector average $669.5M
▼
-86.6% below sector average
Key checks
Key Insights
- In FY2025, cash & equivalents decreased 47.1% year-over-year.
- Ranks #148 out of 207 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.65 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $89.7M | -47.1% |
| FY2024 | $169.5M | +268.6% |
| FY2023 | $46.0M | - |
As of FY2025 · SEC 10-K · Updated Mar 21, 2026